Search | Page 37 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Pharmacokinetic Guided Dose Escalation and Dose Confirmation With Oral Decitabine and Oral CDAi in Patients With MDS

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... stage the selected dose will be confirmed and evaluated for clinical activity, including response rate. ...

    Clinical Trial last updated 04/27/2016 - 2:05pm.

  2. A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... Phase 1 dose escalation (Part A) and expansion (Part B), clinical study of CC-90002, administered by intravenous (IV) infusion, in ...

    Clinical Trial last updated 04/27/2016 - 1:31pm.

  3. A Combination Study of PF-04449913 and Azacitidine In 1st Line MDS, AML and CMML Patients

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... dysplasia, and Chronic Myelomonocytic Leukemia (CMML). This clinical study includes two components: (a) a Phase 1b safety lead in and (b) a ...

    Clinical Trial last updated 04/27/2016 - 1:20pm.

  4. T-cell Depleted Alternative Donor Transplantation

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... ejection fraction < 45%; can be lower if patient is not in clinical cardiac failure and a reduced intensity conditioning regimen is used. ...

    Clinical Trial last updated 04/29/2016 - 3:38pm.

  5. PRO#1278: Fludarabine and Busulfan vs. Fludarabine, Busulfan and Total Body Irradiation (FLUBUTBI)

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... illness likely to interfere with participation in this clinical study   Donor Exclusion Criteria Identical twin Female ...

    Clinical Trial last updated 04/29/2016 - 3:09pm.

  6. Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic

    For more details on this clinical trial, including contact information, please see this trial’s listing on ... Any medical condition which, in the opinion of the clinical investigator, would interfere with the evaluation of the patient. ...

    Clinical Trial last updated 04/29/2016 - 4:33pm.

  7. An Open-Label, Dose-Escalation/Dose-Expansion Safety Study of INCB059872 in Subjects With Advanced Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 11:49am.

  8. An Open-Label, Dose-Escalation Study of INCB054329 in Patients With Advanced Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 11:47am.

  9. Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 11:45am.

  10. T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

    For more details on this clinical trial, including contact information, please see this trial’s listing on clinicaltrials.gov: ...

    Clinical Trial last updated 05/03/2016 - 11:43am.